Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA)

• Status: Completed
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study aims to test the effect of Doxycycline in treatment of uterine bleeding during the use of injectable contraception that contains one hormone "progesterone only".

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Omar Mamdouh Shaaban
• Treatments: Doxycycline; Medroxyprogesterone; Medroxyprogesterone Acetate

Criteria

Inclusion Criteria:

1. Women under DMPA contraception for at least one month.

2. Accept to participate in the trial after receiving adequate information about the trial including information that she is a part of randomization comprising the possibility of receiving new treatment for bleeding or inactive ingredients.

3. Women's ability to keep an accurate menstrual diary for the study.

Exclusion Criteria:

1. Lactating women for the fear of the effect of tetracycline on the breast-fed infant.

2. Patients with already diagnosed local gynecological abnormality.

3. Women receiving treatment for bleeding within the last one month.